Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for transplant patients with Drug-Resistant CMV

NCT ID NCT06439342

Recruiting now Disease control Sponsor: Takeda Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a drug called maribavir in Chinese adults who had a stem cell or organ transplant and have a CMV infection that did not get better with standard treatments. The main goal is to see if maribavir is safe and well-tolerated. Researchers will also check if the drug clears the virus and how often the infection comes back. Participants take maribavir for 8 weeks and visit the clinic 18 times.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CYTOMEGALOVIRUS (CMV) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cytomegalovirus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CYTOMEGALOVIRUS (CMV)

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Anhui Provincial Hospital(The First Affiliated Hospital of USTC)

    RECRUITING

    Hefei, Anhui, 230001, China

  • Guangzhou First People's Hospital

    RECRUITING

    Guangzhou, Guangdong, 510180, China

  • Henan Cancer Hospital

    RECRUITING

    Zhengzhou, Henan, 450004, China

  • Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences

    RECRUITING

    Tianjin, Tianjin Municipality, 300020, China

  • Nanfang Hospital Southern Medical University

    RECRUITING

    Guangzhou, Guangdong, 510515, China

  • Peking University People's Hospital

    RECRUITING

    Beijing, North China, 100044, China

  • The First Affiliated Hospital of Soochow University

    RECRUITING

    Suzhou, Jiangsu, 215006, China

  • The First Affiliated Hospital, Zhejiang University School of Medicine

    RECRUITING

    Hangzhou, Zhejiang, 310003, China

  • The First Affiliated Hospital, Zhejiang University School of Medicine

    RECRUITING

    Hangzhou, Zhejiang, 310003, China

  • The Second Affiliated Hospital, Zhejiang University School of Medicine

    RECRUITING

    Hangzhou, Zhejiang, 310052, China

  • Union Hospital Tongji Medical College Huazhong University of Science and Technology

    RECRUITING

    Wuhan, Hubei, 430022, China

  • Xinqiao Hospital Army Medical University

    RECRUITING

    Chongqing, Chongqing Municipality, 400037, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.